Breakingviews: Merck's mega-deal leaves pharma in need of a fix | Business Information & News | Westlaw

Breakingviews: Merck's mega-deal leaves pharma in need of a fix | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, Breakingviews: Merck's mega-deal leaves pharma in need of a fix, Business Information & News
9/22/14 REUTERS 16:48:21
REUTERS
Copyright © 2014 Thomson Reuters
September 22, 2014
Breakingviews: Merck's mega-deal leaves pharma in need of a fix
Neil Unmack
LONDON (Reuters Breakingviews) - "Anything but pharma" seems to be Merck's M&A philosophy. The German drugs and chemicals maker will buy U.S. life-science group Sigma-Aldrich for $17 billion. The deal makes strategic sense, but leaves the humdrum...
---- Index References ----
Company: SIGMA ALDRICH CORP; MERCK HOEI(MERCK KGAA)
News Subject: (Major Corporations (1MA93))
Industry: (Pharmaceuticals & Biotechnology Industry Highlights (1PH07); Pharmaceuticals (1PH33); Biotechnology (1BI78); Pharmaceuticals & Biotechnology (1PH13))
Language: EN
Other Indexing: (AZ Electronics)
(MCC:OEC); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OEC)
Word Count: 430
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.